Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Human papillomavirus 16"" wg kryterium: Temat


Tytuł:
A novel HPV16 splicing enhancer critical for viral oncogene expression and cell immortalization.
Autorzy:
Jönsson J; Department of Medical Biochemistry and Microbiology, Uppsala University, BMC-B9, 751 23 Uppsala, Sweden.
Wang L; Department of Medical Biochemistry and Microbiology, Uppsala University, BMC-B9, 751 23 Uppsala, Sweden.; Center of Translational Medicine, Zibo Central Hospital, 255036 Zibo, China.
Kajitani N; Department of Medical Biochemistry and Microbiology, Uppsala University, BMC-B9, 751 23 Uppsala, Sweden.
Schwartz S; Department of Medical Biochemistry and Microbiology, Uppsala University, BMC-B9, 751 23 Uppsala, Sweden.
Pokaż więcej
Źródło:
Nucleic acids research [Nucleic Acids Res] 2024 Jan 11; Vol. 52 (1), pp. 316-336.
Typ publikacji:
Journal Article
MeSH Terms:
Human papillomavirus 16*/genetics
Human papillomavirus 16*/metabolism
Oncogene Proteins, Viral*/genetics
Oncogene Proteins, Viral*/metabolism
Repressor Proteins*/metabolism
Keratinocytes*/virology
Humans ; Papillomavirus E7 Proteins/genetics ; Papillomavirus Infections/genetics ; RNA, Messenger/genetics ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł:
Concentration strategies for spiked and naturally present biomarkers in non-invasively collected first-void urine.
Autorzy:
Téblick L; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610, Wilrijk-Antwerp, Belgium. .
Lipovac M; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610, Wilrijk-Antwerp, Belgium.
Burdier FR; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610, Wilrijk-Antwerp, Belgium.
De Smet A; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610, Wilrijk-Antwerp, Belgium.
Bell M; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610, Wilrijk-Antwerp, Belgium.
van den Borst E; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610, Wilrijk-Antwerp, Belgium.; Centre of Medical Genetics, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, 2650, Edegem, Belgium.
Matheeussen V; Department of Microbiology, Antwerp University Hospital (UZA), 2650, Edegem-Antwerp, Belgium.; Department of Medical Microbiology (LMM), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610, Wilrijk-Antwerp, Belgium.; Department of Medical Biochemistry, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences, University of Antwerp, 2610, Wilrijk-Antwerp, Belgium.
Vorsters A; Centre for the Evaluation of Vaccination (CEV), Vaccine & Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, 2610, Wilrijk-Antwerp, Belgium.
Pokaż więcej
Źródło:
European journal of medical research [Eur J Med Res] 2024 Feb 17; Vol. 29 (1), pp. 131. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
Human papillomavirus 16*/genetics
Cell-Free Nucleic Acids*
Humans ; Female ; Biomarkers ; DNA
Czasopismo naukowe
Tytuł:
Epidermal growth factor receptor-dependent stimulation of differentiation by human papillomavirus type 16 E5.
Autorzy:
Trammel J; Department of Microbiology and Immunology, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103, USA.
Amusan O; Department of Microbiology and Immunology, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103, USA.
Hultgren A; Department of Microbiology and Immunology, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103, USA; School of Medicine, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103, USA.
Raikhy G; Department of Microbiology and Immunology, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103, USA.
Bodily JM; Department of Microbiology and Immunology, Louisiana State University Health Sciences Center - Shreveport, Shreveport, LA, 71103, USA. Electronic address: .
Pokaż więcej
Źródło:
Virology [Virology] 2024 Feb; Vol. 590, pp. 109952. Date of Electronic Publication: 2023 Dec 12.
Typ publikacji:
Journal Article
MeSH Terms:
Human papillomavirus 16*/physiology
Oncogene Proteins, Viral*/genetics
Oncogene Proteins, Viral*/metabolism
Papillomavirus Infections*
Humans ; ErbB Receptors/genetics ; ErbB Receptors/metabolism ; Keratinocytes ; Cell Differentiation
Czasopismo naukowe
Tytuł:
Development of a touchdown droplet digital PCR assay for the detection and quantitation of human papillomavirus 16 and 18 from self-collected anal samples.
Autorzy:
Haqshenas G; Department of Obstetrics and Gynaecology, University of Melbourne , Melbourne, Victoria, Australia.; Centre for Women's Infectious Diseases, The Royal Women's Hospital , Melbourne, Victoria, Australia.; Murdoch Children's Research Institute , Melbourne, Victoria, Australia.
Garland SM; Department of Obstetrics and Gynaecology, University of Melbourne , Melbourne, Victoria, Australia.; Centre for Women's Infectious Diseases, The Royal Women's Hospital , Melbourne, Victoria, Australia.; Murdoch Children's Research Institute , Melbourne, Victoria, Australia.
Balgovind P; Centre for Women's Infectious Diseases, The Royal Women's Hospital , Melbourne, Victoria, Australia.; Murdoch Children's Research Institute , Melbourne, Victoria, Australia.
Cornall A; Department of Obstetrics and Gynaecology, University of Melbourne , Melbourne, Victoria, Australia.; Centre for Women's Infectious Diseases, The Royal Women's Hospital , Melbourne, Victoria, Australia.; Murdoch Children's Research Institute , Melbourne, Victoria, Australia.
Danielewski J; Centre for Women's Infectious Diseases, The Royal Women's Hospital , Melbourne, Victoria, Australia.; Murdoch Children's Research Institute , Melbourne, Victoria, Australia.
Molano M; Centre for Women's Infectious Diseases, The Royal Women's Hospital , Melbourne, Victoria, Australia.
Machalek DA; Centre for Women's Infectious Diseases, The Royal Women's Hospital , Melbourne, Victoria, Australia.; Murdoch Children's Research Institute , Melbourne, Victoria, Australia.; The Kirby Institute, UNSW Sydney , Sydney, New South Wales, Australia.
Murray G; Department of Obstetrics and Gynaecology, University of Melbourne , Melbourne, Victoria, Australia.; Centre for Women's Infectious Diseases, The Royal Women's Hospital , Melbourne, Victoria, Australia.; Murdoch Children's Research Institute , Melbourne, Victoria, Australia.
Pokaż więcej
Źródło:
Microbiology spectrum [Microbiol Spectr] 2023 Dec 12; Vol. 11 (6), pp. e0183623. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Human papillomavirus 16*/genetics
Papillomavirus Infections*/diagnosis
Humans ; Anal Canal ; Polymerase Chain Reaction ; Papillomaviridae/genetics
Czasopismo naukowe
Tytuł:
Evidence for direct interaction between the oncogenic proteins E6 and E7 of high-risk human papillomavirus (HPV).
Autorzy:
Lim J; Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Tuebingen, Germany.
Lilie H; Institute of Biochemistry and Biotechnology, Martin-Luther-University Halle-Wittemberg, Halle-Wittemberg, Germany.
Kalbacher H; Interfaculty Institute of Biochemistry, Eberhard-Karls-University Tuebingen, Tuebingen, Germany.
Roos N; Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Tuebingen, Germany.
Frecot DI; Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Tuebingen, Germany.
Feige M; Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Tuebingen, Germany.
Conrady M; Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Tuebingen, Germany.
Votteler T; Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Tuebingen, Germany.
Cousido-Siah A; Equipe Labellisée Ligue 2015, Department of Integrative Biology, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS, INSERM, UdS, Illkirch, France.
Corradini Bartoli G; Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Tuebingen, Germany.
Iftner T; Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: .
Trave G; Equipe Labellisée Ligue 2015, Department of Integrative Biology, Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS, INSERM, UdS, Illkirch, France.
Simon C; Institute of Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Tuebingen, Germany. Electronic address: .
Pokaż więcej
Źródło:
The Journal of biological chemistry [J Biol Chem] 2023 Aug; Vol. 299 (8), pp. 104954. Date of Electronic Publication: 2023 Jun 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human papillomavirus 16*/genetics
Human papillomavirus 16*/metabolism
Oncogene Proteins, Viral*/genetics
Oncogene Proteins, Viral*/metabolism
Papillomavirus E7 Proteins*/genetics
Papillomavirus E7 Proteins*/metabolism
Papillomavirus Infections*
Animals ; Humans ; Carcinogenesis ; Human Papillomavirus Viruses ; Neoplasms
Czasopismo naukowe
Tytuł:
Genetic variation of E6 and E7 genes of human papillomavirus type 16 from central China.
Autorzy:
Li T; Department of Laboratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434020, China.
Yang Z; Department of Laboratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434020, China.
Zhang C; Department of Laboratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434020, China.
Wang S; Department of Laboratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434020, China.
Mei B; Department of Laboratory Medicine, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434020, China. .
Pokaż więcej
Źródło:
Virology journal [Virol J] 2023 Sep 27; Vol. 20 (1), pp. 217. Date of Electronic Publication: 2023 Sep 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human papillomavirus 16*/genetics
Papillomavirus Infections*/epidemiology
Uterine Cervical Neoplasms*/epidemiology
Female ; Humans ; China/epidemiology ; Epitopes, B-Lymphocyte/genetics ; Genetic Variation ; Human Papillomavirus Viruses ; Nucleotides ; Phylogeny
Czasopismo naukowe
Tytuł:
Biomolecular Condensation of the Human Papillomavirus E2 Master Regulator with p53: Implications in Viral Replication.
Autorzy:
Borkosky SS; Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA) - CONICET, Av. Patricias Argentinas 435, 1405 Buenos Aires, Argentina. Electronic address: .
Fassolari M; Fundación para Investigaciones Biológicas Aplicadas (FIBA), Instituto de Investigaciones en Biodiversidad y Biotecnología (INBIOTEC)-CONICET, Mar del Plata, Argentina.
Campos-León K; Division of Immunity and Infection, School of Medicine, University of Birmingham, United Kingdom.
Rossi AH; Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA) - CONICET, Av. Patricias Argentinas 435, 1405 Buenos Aires, Argentina.
Salgueiro M; Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA) - CONICET, Av. Patricias Argentinas 435, 1405 Buenos Aires, Argentina.
Pascuale CA; Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA) - CONICET, Av. Patricias Argentinas 435, 1405 Buenos Aires, Argentina.
Martínez RP; Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA) - CONICET, Av. Patricias Argentinas 435, 1405 Buenos Aires, Argentina.
Gaston K; School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham, United Kingdom.
de Prat Gay G; Fundación Instituto Leloir, Instituto de Investigaciones Bioquímicas de Buenos Aires (IIBBA) - CONICET, Av. Patricias Argentinas 435, 1405 Buenos Aires, Argentina. Electronic address: .
Pokaż więcej
Źródło:
Journal of molecular biology [J Mol Biol] 2023 Aug 15; Vol. 435 (16), pp. 167889. Date of Electronic Publication: 2022 Nov 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
DNA Replication*
DNA-Binding Proteins*/chemistry
DNA-Binding Proteins*/metabolism
Human papillomavirus 16*/physiology
Oncogene Proteins, Viral*/chemistry
Oncogene Proteins, Viral*/metabolism
Tumor Suppressor Protein p53*/genetics
Tumor Suppressor Protein p53*/metabolism
Virus Replication*/physiology
Biomolecular Condensates*/metabolism
Biomolecular Condensates*/virology
Humans ; Cell Line, Tumor ; Chromatin/chemistry ; Chromatin/metabolism ; DNA/chemistry ; DNA/metabolism ; Papillomavirus Infections/virology ; Protein Domains
Czasopismo naukowe
Tytuł:
Systemic delivery of specific and efficient CRISPR/Cas9 system targeting HPV16 oncogenes using LL-37 antimicrobial peptide in C57BL/6 mice.
Autorzy:
Khairkhah N; Department of Molecular Medicine, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
Bolhassani A; Department of Hepatitis and AIDS, Pasteur Institute of Iran, Tehran, Iran.
Rajaei F; Cellular and Molecular Research Center, Research Institute for Non-communicable Disease, Qazvin University of Medical Sciences, Qazvin, Iran.
Najafipour R; Department of Molecular Medicine, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.; Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Journal of medical virology [J Med Virol] 2023 Jul; Vol. 95 (7), pp. e28934.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human papillomavirus 16*/genetics
CRISPR-Cas Systems*
Mice ; Animals ; Humans ; Antimicrobial Peptides ; Mice, Inbred C57BL ; Oncogenes
Czasopismo naukowe
Tytuł:
Induction of epithelial to mesenchymal transition in HPV16 E6/E7 oncogene transfected C33A cell line.
Autorzy:
Chakraborti S; Centre for Biomaterials, Cellular and Molecular Theranostics, Vellore Institute of Technology, Vellore, Tamilnadu, India.
Karmakar A; Department of Data Science, Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, Karnataka, India.
Guha R; School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamilnadu, India.
Ngan C; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Kumar Das R; Centre for Biomaterials, Cellular and Molecular Theranostics, Vellore Institute of Technology, Vellore, Tamilnadu, India; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia. Electronic address: .
Whitaker N; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia.
Pokaż więcej
Źródło:
Tissue & cell [Tissue Cell] 2023 Jun; Vol. 82, pp. 102041. Date of Electronic Publication: 2023 Feb 17.
Typ publikacji:
Journal Article
MeSH Terms:
beta Catenin*/genetics
beta Catenin*/metabolism
Human papillomavirus 16*/genetics
Human papillomavirus 16*/metabolism
Epithelial-Mesenchymal Transition/genetics ; Cell Line, Tumor ; Transcription Factors/metabolism ; Oncogenes
Czasopismo naukowe
Tytuł:
HPV16 status predicts potential protein biomarkers and therapeutics in head and neck squamous cell carcinoma.
Autorzy:
Kori M; Department of Bioengineering, Marmara University, Istanbul, Turkey. Electronic address: .
Arga KY; Department of Bioengineering, Marmara University, Istanbul, Turkey; Genetic and Metabolic Diseases Research and Investigation Center, Marmara University, Istanbul, Turkey. Electronic address: .
Pokaż więcej
Źródło:
Virology [Virology] 2023 May; Vol. 582, pp. 90-99. Date of Electronic Publication: 2023 Apr 07.
Typ publikacji:
Journal Article
MeSH Terms:
Human papillomavirus 16*/genetics
Head and Neck Neoplasms*/drug therapy
Head and Neck Neoplasms*/pathology
Head and Neck Neoplasms*/virology
Prognosis ; Biomarkers, Tumor/analysis ; Protein Interaction Maps ; Humans ; Gene Expression Profiling
Czasopismo naukowe
Tytuł:
Deregulation of host gene expression by HPV16 E8^E2 knock-out genomes is due to increased productive replication.
Autorzy:
Kuehner F; Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Elfriede-Aulhorn-Str. 6, D72076, Tuebingen, Germany.
Straub E; Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Elfriede-Aulhorn-Str. 6, D72076, Tuebingen, Germany.
Iftner T; Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Elfriede-Aulhorn-Str. 6, D72076, Tuebingen, Germany.
Stubenrauch F; Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tuebingen, Elfriede-Aulhorn-Str. 6, D72076, Tuebingen, Germany. Electronic address: .
Pokaż więcej
Źródło:
Virology [Virology] 2023 Apr; Vol. 581, pp. 39-47. Date of Electronic Publication: 2023 Feb 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human papillomavirus 16*/metabolism
Oncogene Proteins, Viral*/genetics
Oncogene Proteins, Viral*/metabolism
Humans ; Virus Replication ; Cell Line ; Cell Differentiation ; Gene Expression ; Keratinocytes
Czasopismo naukowe
Tytuł:
Evaluation of human papillomavirus type 16 viral load and genome physical status in Iranian women with cervical disease.
Autorzy:
Setayeshi S; Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
Hasanzadeh A; Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran.
Yahyapour Y; Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Alizadeh A; Health Products Safety Research Center, Qazvin University of Medical Sciences, Qazvin, Iran.
Ghorbani H; Department of Pathology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Nokhostin F; Department of Obstetrics and Gynecology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Bagheri M; Department of Microbiology and Biotechnology, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Sadeghi F; Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran. .
Pokaż więcej
Źródło:
Molecular biology reports [Mol Biol Rep] 2024 Mar 11; Vol. 51 (1), pp. 411. Date of Electronic Publication: 2024 Mar 11.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/pathology
Oncogene Proteins, Viral*/genetics
Papillomavirus Infections*
Precancerous Conditions*
Female ; Humans ; Human papillomavirus 16/genetics ; DNA-Binding Proteins/genetics ; Iran ; Viral Load/genetics ; DNA, Viral/genetics
Czasopismo naukowe
Tytuł:
Human papillomavirus and p16 in oropharyngeal squamous cell carcinomas: A systematic review and meta-analysis.
Autorzy:
Lu Y; School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.; School of Public Health, Sun Yat-sen University, Guangzhou, China.
Clifford GM; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Fairley CK; Melbourne Sexual Health Centre, The Alfred, Melbourne, Australia.; Central Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia.
Grulich AE; Kirby Institute, The University of New South Wales, Sydney, Australia.
Garland SM; Royal Women's Hospital, University of Melbourne, Murdoch Children's Research Institute, Melbourne, Australia.
Xiao F; School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.
Wang Y; School of Public Health, the Key Laboratory of Environmental Pollution Monitoring and Disease Control, Ministry of Education, Guizhou Medical University, Guiyang, China.
Zou H; School of Public Health, Fudan University, Shanghai, China.; Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics and Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.; School of Public Health, Southwest Medical University, Luzhou, China.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 01; Vol. 154 (5), pp. 830-841. Date of Electronic Publication: 2023 Oct 20.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Carcinoma, Squamous Cell*/metabolism
Head and Neck Neoplasms*
Oropharyngeal Neoplasms*
Papillomavirus Infections*/complications
Papillomavirus Infections*/epidemiology
Papillomavirus Infections*/metabolism
Humans ; Cyclin-Dependent Kinase Inhibitor p16/genetics ; DNA, Viral/genetics ; DNA, Viral/analysis ; Human papillomavirus 16/genetics ; Human papillomavirus 16/metabolism ; Human Papillomavirus Viruses ; Papillomaviridae/genetics ; Papillomaviridae/metabolism ; Squamous Cell Carcinoma of Head and Neck
Czasopismo naukowe
Tytuł:
Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
Autorzy:
Kang SW; Department of Obstetrics & Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer TherapeutiX, Asan Medical Center, Seoul, Republic of Korea.
Kang OJ; Department of Obstetrics & Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer TherapeutiX, Asan Medical Center, Seoul, Republic of Korea.
Lee JY; Department of Obstetrics & Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer TherapeutiX, Asan Medical Center, Seoul, Republic of Korea.
Kim H; EnhancedBio Inc., Seoul, Republic of Korea.
Jung H; EnhancedBio Inc., Seoul, Republic of Korea.
Kim H; EnhancedBio Inc., Seoul, Republic of Korea.
Lee SW; Department of Obstetrics & Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer TherapeutiX, Asan Medical Center, Seoul, Republic of Korea.
Kim YM; Department of Obstetrics & Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.; Asan Preclinical Evaluation Center for Cancer TherapeutiX, Asan Medical Center, Seoul, Republic of Korea.
Choi EK; Asan Preclinical Evaluation Center for Cancer TherapeutiX, Asan Medical Center, Seoul, Republic of Korea.; Department of Radiation Oncology, ASAN Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Feb 16; Vol. 19 (2), pp. e0298815. Date of Electronic Publication: 2024 Feb 16 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/drug therapy
Uterine Cervical Neoplasms*/genetics
Uterine Cervical Neoplasms*/pathology
Oncogene Proteins, Viral*/genetics
Oncogene Proteins, Viral*/metabolism
Liposomes*
Nanoparticles*
Female ; Humans ; Animals ; Mice ; RNA, Small Interfering/genetics ; Cisplatin/pharmacology ; Cisplatin/therapeutic use ; Human papillomavirus 16/genetics ; Human papillomavirus 16/metabolism ; Tumor Suppressor Protein p53/genetics ; Mice, Nude ; Heterografts ; Cell Line, Tumor ; Papillomavirus E7 Proteins/genetics ; Papillomavirus E7 Proteins/metabolism ; RNA, Messenger/genetics
Czasopismo naukowe
Tytuł:
HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
Autorzy:
Zhang J; Department of Gynecology, Dalian Women and Children's Medical Group, Dalian, Liaoning, China.
Yu X; Department of Gynecology, Dalian Women and Children's Medical Group, Dalian, Liaoning, China.
Guo Y; Department of Gynecology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Wang D; Department of Gynecology, Dalian Women and Children's Medical Group, Dalian, Liaoning, China.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2024 Feb; Vol. 13 (3), pp. e6875. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
MicroRNAs*/genetics
MicroRNAs*/metabolism
Uterine Cervical Neoplasms*/pathology
Female ; Humans ; Down-Regulation ; Gene Expression Regulation, Neoplastic ; Human papillomavirus 16/genetics ; Human papillomavirus 16/metabolism
Czasopismo naukowe
Tytuł:
The association between high-risk human papillomavirus and oral lichen planus.
Autorzy:
Mohammadi M; Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.
Abbaszadeh H; Department of Oral and Maxillofacial Pathology, Faculty of Dentistry, Birjand University of Medical Sciences, Birjand, Iran.
Mohtasham N; Oral and Maxillofacial Disease Research Center, Faculty of Dentistry, Mashhad University of Medical Science, Mashhad, Iran.
Salehiniya H; Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Shafaie E; Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Pokaż więcej
Źródło:
Clinical and experimental dental research [Clin Exp Dent Res] 2023 Feb; Vol. 9 (1), pp. 93-99. Date of Electronic Publication: 2023 Jan 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human papillomavirus 16*/genetics
Lichen Planus, Oral*/pathology
Papillomavirus Infections*/complications
Papillomavirus Infections*/epidemiology
Human papillomavirus 18*/genetics
Humans ; Case-Control Studies ; Human Papillomavirus Viruses ; Papillomaviridae/genetics
Czasopismo naukowe
Tytuł:
The expression of Oct3/4A mRNA and not its isoforms is upregulated by the HPV16 E7 oncoprotein.
Autorzy:
Gómez-Gómez Y; Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Edificio C primer piso, Av. Lázaro Cárdenas S/N, Ciudad Universitaria sur, 39090, Chilpancingo, Guerrero, México.
Organista-Nava J; Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Edificio C primer piso, Av. Lázaro Cárdenas S/N, Ciudad Universitaria sur, 39090, Chilpancingo, Guerrero, México. .
Clemente-Periván SI; Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Edificio C primer piso, Av. Lázaro Cárdenas S/N, Ciudad Universitaria sur, 39090, Chilpancingo, Guerrero, México.
Lagunas-Martínez A; Centro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, 62100, Cuernavaca, Morelos, México.
Salmerón-Bárcenas EG; Departamento de Biomedicina Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, 07360, Ciudad de México, Mexico.
Villanueva-Morales D; Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Edificio C primer piso, Av. Lázaro Cárdenas S/N, Ciudad Universitaria sur, 39090, Chilpancingo, Guerrero, México.
Ayala-Reyna DY; Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Edificio C primer piso, Av. Lázaro Cárdenas S/N, Ciudad Universitaria sur, 39090, Chilpancingo, Guerrero, México.
Del Carmen Alarcón-Romero L; Laboratorio de Citopatología, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, 39090, Chilpancingo, Guerrero, México.
Ortiz-Ortiz J; Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Edificio C primer piso, Av. Lázaro Cárdenas S/N, Ciudad Universitaria sur, 39090, Chilpancingo, Guerrero, México.
Jiménez-López MA; Instituto Estatal de Cancerología 'Dr. Arturo Beltrán Ortega', 39570, Acapulco, Guerrero, México.
Bello-Rios C; Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Edificio C primer piso, Av. Lázaro Cárdenas S/N, Ciudad Universitaria sur, 39090, Chilpancingo, Guerrero, México.
Leyva-Vázquez MA; Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Edificio C primer piso, Av. Lázaro Cárdenas S/N, Ciudad Universitaria sur, 39090, Chilpancingo, Guerrero, México.
Illades-Aguiar B; Laboratorio de Biomedicina Molecular, Facultad de Ciencias Químico Biológicas, Universidad Autónoma de Guerrero, Edificio C primer piso, Av. Lázaro Cárdenas S/N, Ciudad Universitaria sur, 39090, Chilpancingo, Guerrero, México. .
Pokaż więcej
Źródło:
Molecular biology reports [Mol Biol Rep] 2023 Feb; Vol. 50 (2), pp. 981-991. Date of Electronic Publication: 2022 Nov 15.
Typ publikacji:
Journal Article
MeSH Terms:
Human papillomavirus 16*/genetics
Human papillomavirus 16*/metabolism
Uterine Cervical Neoplasms*/metabolism
Octamer Transcription Factor-3*/genetics
Octamer Transcription Factor-3*/metabolism
Female ; Humans ; Alternative Splicing/genetics ; Protein Isoforms/genetics ; Protein Isoforms/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Transcription Factors/genetics
Czasopismo naukowe
Tytuł:
Cost-effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model-based analysis.
Autorzy:
Portnoy A; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Pedersen K; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
Sy S; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Tropé A; Section for Cervical Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Engesaeter B; Section for Cervical Cancer Screening, Cancer Registry of Norway, Oslo, Norway.
Kim JJ; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Burger EA; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 1073-1081. Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/diagnosis
Uterine Cervical Neoplasms*/prevention & control
Papillomavirus Infections*/diagnosis
Papillomavirus Infections*/prevention & control
Papillomavirus Infections*/epidemiology
Adolescent ; Pregnancy ; Female ; Humans ; Adult ; Human Papillomavirus Viruses ; Cost-Benefit Analysis ; Human papillomavirus 16/genetics ; Triage ; Early Detection of Cancer ; Human papillomavirus 18/genetics ; Colposcopy ; Norway
Czasopismo naukowe
Tytuł:
High-risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020.
Autorzy:
Boni SP; PAC-CI Research Program, Abidjan, Côte d'Ivoire.; National Cancer Control Program, Abidjan, Côte d'Ivoire.
Tenet V; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Horo A; Gynecology and Obstetrics Department, University Hospital of Yopougon, Abidjan, Côte d'Ivoire.
Heideman DAM; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Bleeker MCG; Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
Tanon A; Infectious and Tropical Diseases Department, University Hospital of Treichville, Abidjan, Côte d'Ivoire.
Mian B; Gynecology and Obstetrics Department, University Hospital of Cocody, Abidjan, Côte d'Ivoire.
Mohenou ID; Pathology Department, University Hospital of Cocody, Abidjan, Côte d'Ivoire.
Ekouevi DK; PAC-CI Research Program, Abidjan, Côte d'Ivoire.; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, Bordeaux, France.; Faculté des Sciences de la Santé, Département de Santé Publique, Université de Lomé, Lomé, Togo.
Gheit T; Epigenomics and Mechanisms Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Didi-Kouko Coulibaly J; Alassane Ouattara National Center of Oncology and Radiotherapy (CNRAO), Abidjan, Côte d'Ivoire.
Tchounga BK; Elizabeth Glazer Paediatric AIDS Foundation, Yaoundé, Cameroon.
Adoubi I; National Cancer Control Program, Abidjan, Côte d'Ivoire.; Oncology Department, University Hospital of Treichville, Abidjan, Côte d'Ivoire.
Clifford GM; Early Detection, Prevention and Infections Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
Jaquet A; University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, Bordeaux, France.
Pokaż więcej
Corporate Authors:
on behalf The IeDEA West Africa Collaboration
Źródło:
International journal of cancer [Int J Cancer] 2024 Mar 15; Vol. 154 (6), pp. 962-968. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article
MeSH Terms:
Uterine Cervical Neoplasms*/epidemiology
Papillomavirus Infections*/complications
Papillomavirus Infections*/epidemiology
HIV Infections*/complications
HIV Infections*/epidemiology
Human Papillomavirus Viruses*
Alphapapillomavirus*
Female ; Humans ; Middle Aged ; Cote d'Ivoire/epidemiology ; Human papillomavirus 18 ; Human papillomavirus 16 ; HIV ; Prevalence
SCR Organism:
human papillomavirus 45; human papillomavirus 35
Czasopismo naukowe
Tytuł:
MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2.
Autorzy:
Sinha A; National Institute of Biomedical Genomics, P.O.: N.S.S, Kalyani, 741251, West Bengal, India.
Ghosh A; National Institute of Biomedical Genomics, P.O.: N.S.S, Kalyani, 741251, West Bengal, India.
Ghosh A; National Institute of Biomedical Genomics, P.O.: N.S.S, Kalyani, 741251, West Bengal, India.
Mathai S; Tata Medical Center, Kolkata, West Bengal, India.
Bhaumik J; Tata Medical Center, Kolkata, West Bengal, India.
Mukhopadhyay A; Kolkata Gynecological Oncology Trials and Translational Research Group, Kolkata, West Bengal, India.
Maitra A; National Institute of Biomedical Genomics, P.O.: N.S.S, Kalyani, 741251, West Bengal, India.
Biswas NK; National Institute of Biomedical Genomics, P.O.: N.S.S, Kalyani, 741251, West Bengal, India.
Sengupta S; National Institute of Biomedical Genomics, P.O.: N.S.S, Kalyani, 741251, West Bengal, India. .
Pokaż więcej
Źródło:
Clinical epigenetics [Clin Epigenetics] 2024 Mar 10; Vol. 16 (1), pp. 40. Date of Electronic Publication: 2024 Mar 10.
Typ publikacji:
Journal Article
MeSH Terms:
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Uterine Cervical Neoplasms*/pathology
Oncogene Proteins, Viral*/genetics
Oncogene Proteins, Viral*/metabolism
Female ; Humans ; Histones/metabolism ; Down-Regulation ; Human papillomavirus 16/genetics ; DNA Methylation ; Papillomavirus E7 Proteins/genetics ; Papillomavirus E7 Proteins/metabolism ; Chromatin/metabolism ; Enhancer of Zeste Homolog 2 Protein/genetics ; Enhancer of Zeste Homolog 2 Protein/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies